Navigation Links
No Clear Winner in Diabetes Treatment Trial
Date:9/21/2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...SNewswire/ -- The Pew Charitable Trusts announced ...chemical and food safety programs, in its Health &... formerly deputy staff director and general counse...c Works, brings nearly 25 years of experience in e... , , "We are excited to be joined by such an ex...
(Date:1/8/2009).... Christine Siu and Jason Brown, Ph.D. Promoted t... and STAMFORD, Conn., Jan. 8 Thoma...capital firm that invests in life science and medi...otion of three members of its investment team. Ka...e Siu and Jason Brown have been promoted to Vice P...
(Date:1/8/2009)...-USNewswire/ -- A proposal by the State of Indiana...n,s Home has prompted the 125,000-member American ...Mid-Winter conference January 10-12, 2009, in orde...nanimous opposition to the proposal. , , The Le... direct and in-kind support to the home, is among ...
(Date:1/8/2009)...e/ -- The physicians of Northern Lake Medical,Ltd...orthern Illinois,communities, announced today tha... (Photo: http://www.newscom.com/cgi-bin/prnh/2...ine physicians serve patients through clinics in,... and Fox Lake. , "The Northern Lake Medical...
Breaking Medicine News(10 mins):Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2Health News:Northern Lake Medical to Join Aurora Health Care 2Health News:Northern Lake Medical to Join Aurora Health Care 3
...se Priya Ranjan Dasmunsi, Information and Broadcas...roved for a six million dollar scheme to join the ...C). It helps to prevent and improve cancer treat...ll help in the development of cancer vaccine in In...
... found that the fear of death before voting had an... Analyses of Social Issues and Public policy repor...004 presidential election in US. Researchers felt ...tape before the election had an impact on the psyc...
... the University of California have now established...ons, garlic, beans, carrot, corn, dark leafy// veg...isk by as much as 50%. The study is based on inter...ts and 1, 700 controls. The new research has been ...
...Hund and her team from University of Illinois have...derwent sexual abuse during their childhood. Eatin... psychological stress and depression in earlier st...ave published the results of their work in the Jou...
Other Medicine News:
(Date:1/8/2009)...n an ongoing Phase Ib trial demonstrated a 2.5 log..., Conference Call Today at 8:30AM EST , , SAN...armaceuticals, Inc. (Nasdaq: ANDS ) today announ...ase Ib clinical trial of ANA598, the Company,s inv... ANA598 was very well-tolerated and demonstrated p...
(Date:1/7/2009)...ewswire/ -- Scientists have identified mutations i... in children with acute lymphoblastic leukemia (AL...research is needed to determine how changes in the...a relapse, the findings are likely to provide the ...sk of treatment failure. By using a molecular test...
(Date:1/7/2009)... ImQuest Life Sciences announced today the success...nd Drug Administration to initiate human clinical ...r IQP-0410. ImQuest anticipates initiating their P...410 is a novel small molecule inhibitor of HIV whi...criptase inhibitor (NNRTI). The compound possesses...
(Date:1/7/2009)...n Puhua Hospital Stem Cells Center ( http://www.st...stem cells to effectively treat neurological disor... additions to its medical and research staff that ...bilities for growing numbers of incoming internati...distinguished Dr. Jiang Ping, who was named Chief ...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Sharps Compliance Corp Announces Appointment of Al Aladwani as its Senior Vice President of Operations 14951 1Sharps Compliance Corp Announces Appointment of Al Aladwani as its Senior Vice President of Operations 14951 2Sharps Compliance Corp Announces Appointment of Al Aladwani as its Senior Vice President of Operations 14951 3Risky teen behavior may not occur at home or school 3A but how to track 3F 14948 1Risky teen behavior may not occur at home or school 3A but how to track 3F 14948 2China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents 14944 1China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents 14944 2CMPMedica Expands SearchMedica com with Multiple Additional Vertical Search Applications co developed with Convera 28R 29 4144 1CMPMedica Expands SearchMedica com with Multiple Additional Vertical Search Applications co developed with Convera 28R 29 4144 2CMPMedica Expands SearchMedica com with Multiple Additional Vertical Search Applications co developed with Convera 28R 29 4144 3
...E)--Jul 5, 2007 - Array BioPharma Inc.,(Nasdaq: AR...er,Robert E. Conway, will speak at the C.E Unterb...n New York City. The public is,welcome to particip...ay BioPharma website. -0-, ,Event: C.E Un...er: Robert E. Conway, Chief Executive Officer...
...UNSWICK, New Jersey, July 03, 2007,/PRNewswire-Fir...NA,company, announced today that J. Michael French...nterberg, Towbin Emerging Growth,Opportunities Con...e Mandarin Oriental Hotel in New York. , A live au...on,the "Investors" section of the company,s websit...
Other Medicine Technology:Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin,Emerging Growth Opportunities Conference 2
Central platform with integrated neck. Piston assembly fits into neck of platform utilizing an internal spring to recoil to ready position after use. Cutting block fits into precision milled cavity i
TLS Surgical Markers allows the surgeon to effectively diagram incision sites with a scrub-resistant, gentian violet ink. All TLS Surgical Markers are provided sterile, with a ruler and are individua
Periosteal elevator, freer.
The Surgifoam* absorbable gelatin sponge, U.S.P. is a sterile, water-insoluble, malleable, porcine gelatin absorbable sponge intended for hemostatic use by applying to a bleeding surface. The sponge
Medicine Products: